Funded Grants

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Official
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-02 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 5R37CA269649-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Stabile, Laura P.

University Of Pittsburgh At Pittsburgh
United States

Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis 5R21CA259787-02 PAR-20-292 (R21 Clinical Trial Optional) Claire Zhu, Ph.D.
Spira, Avrum E

Boston University Medical Campus
United States

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy 1U2CCA233238-01 Richard Mazurchuk, Ph.D.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-04 Rachel Altshuler, Ph.D.
Sowers, Lawrence C

University Of Texas Med Br Galveston
United States

Cytosine Deamination Adducts and Cancer Etiology 5R01CA228085-05 Wendy Wang, Ph.D., M.Sc.
Sorror, Mohamed

Fred Hutchinson Cancer Center
United States

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality 5R01CA227092-06 Marjorie Perloff, M.D.
Sorger, Peter Karl

Harvard Medical School
United States

Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center) 3U2CCA233262-01S2 Sudhir Srivastava, Ph.D., M.P.H.
Soragni, Alice

University Of California Los Angeles
United States

Targeting p53 conformational defects to arrest carcinogenesis 5R01CA240718-05 Goli Samimi, Ph.D., M.P.H.
Song, Ming

University Of Louisville
United States

Dietary fructose and NASH/HCC progression 1R21CA290420-01 Amit Kumar, Ph.D.